Cambria Investment Management’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q1 | – | Sell |
-11,772
| Closed | -$2.82M | – | 279 |
|
2021
Q4 | $2.82M | Buy |
11,772
+1,199
| +11% | +$288K | 0.47% | 103 |
|
2021
Q3 | $2.99M | Sell |
10,573
-436
| -4% | -$123K | 0.55% | 53 |
|
2021
Q2 | $3.81M | Buy |
11,009
+1,526
| +16% | +$528K | 0.65% | 39 |
|
2021
Q1 | $2.65M | Buy |
9,483
+6,967
| +277% | +$1.95M | 0.53% | 49 |
|
2020
Q4 | $616K | Sell |
2,516
-136
| -5% | -$33.3K | 0.21% | 132 |
|
2020
Q3 | $752K | Sell |
2,652
-171
| -6% | -$48.5K | 0.28% | 72 |
|
2020
Q2 | $755K | Sell |
2,823
-562
| -17% | -$150K | 0.28% | 62 |
|
2020
Q1 | $1.07M | Sell |
3,385
-491
| -13% | -$155K | 0.4% | 41 |
|
2019
Q4 | $1.15M | Buy |
+3,876
| New | +$1.15M | 0.3% | 93 |
|